News

Do you as a company with a brilliant idea to solve a healthcare issue need to hire a Chief Medical Officer(CMO) at an early stage of your development?

The answer is NO, a perspective


Lets look at a typical job responsibility of a CMO


To perform this job successfully, an individual must be able to perform the following:

Leveraging the UK’s renowned contract research sector to boost industrial growth


Medicines Discovery Catapult’s Virtual R&D Discovery Services platform announce twenty-two partnerships


Today [26 April 2019], Medicines Discovery Catapult announces the launch of twenty-two partnerships with UK contract research organisations (CROs). The aim is to boost UK life sciences R&D and international competitiveness by channelling high quality projects through best-in-class service providers.

InVisionFirst®-Lung demonstrated excellent concordance with tissue profiling and detected 26% more actionable alterations than
standard-of-care testing


Data from two prospective U.S. trials published in Journal Clinical Oncology – Precision Oncology

CAP Accreditation is Awarded to Clinical Laboratories Meeting the Highest Standards in Laboratory Practices


Research Triangle Park, NC and Cambridge, UK, April 18, 2019 -- Inivata, a leader in liquid biopsy, today announces that it has received Accreditation from the College of American Pathologists (CAP) for its CLIA laboratory in Research Triangle Park, North Carolina. The CAP Accreditation is awarded to laboratories which meet stringent quality, accuracy and consistency requirements. 

16 April 2019 – Genomics England has announced today the successful completion of the first phase of its collaboration with Inivata and Thermo Fisher Scientific. This is part of a pilot project, undertaken by Genomics England in collaboration with industry, to:

Further Milestone from Janssen on NDA Approval by the US FDA of BALVERSA™ (erdafitinib) for the Treatment of Urothelial Cancer

Businesses across East Anglia are turning to placement students from the University of East Anglia (UEA) to help innovate and grow their organisations.


Increasing numbers of businesses are hosting placement students with many offering them permanent positions when they graduate.

AMSBIO announces XerumFree™ - a new concept in cell culture that allows you to culture cells without the use of serum.

XerumFree™ has been developed taking into account what is missing in traditional basal cell culture media to sustain growth of all cell types, which is a nutritional approach at the cellular level. 

Detachin™ Cell Detachment Solution from AMSBIO is a high-performance alternative to Trypsin/EDTA for detaching adherent cells from in vitro growth vessels. Detachin™ provides rapid, gentle, and effective detachment of a wide variety of adherent cells, including primary cells, from all commercially available tissue culture plasticware.

Pages